Research Portfolio
We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), research program area, and disease.
If you are interested in a specific research program area, browse the recently funded research by program area.
To browse active grants you may also wish to view the 2021 Grants Portfolio publication.
Filter for Grant pages
Keyword Search for Grant pages
Search Results
|
Title |
Institution |
Investigator |
Status |
Research Program Area |
| 02907: Ultrasound-guided Histotripsy Ablation of Canine Brain Tumors through an Acoustically Transparent Cranial Window | Virginia-Maryland Regional College of Veterinary Medicine | John Rossmeisl, DVM, MS | Open | Oncology |
| 02880: Enhanced Surgical Margin Imaging with Polarization-sensitive Optical Coherence Tomography in Canine Soft Tissue Sarcoma and Mammary Tumors | The Ohio State University | Laura Selmic, BVetMed, MPH | Open | Oncology |
| 02879: Use of CRISPR-based Genome-wide Approach for Identification of Vulnerabilities in Canine Oral Melanoma | R(D)SVS and Roslin Institute, University of Edinburgh | Maciej Parys, DVM, PhD | Open | Oncology |
| 02920: Continued Investigation into Tumor-permissive Collagen Signatures in Canine Mammary Gland Tumors: Development of Prognostic Markers and Targeted Therapies for Improved Outcomes | University of Pennsylvania | Susan W. Volk, VMD, PhD | Open | Oncology |
| 02855-A: Repurposing Drugs to Modulate Myeloid-derived Suppressor Cells (MDSCs) in Canine Soft Tissue Sarcomas | Louisiana State University | Sita Withers, BVSc, PhD | Open | Oncology |
| 02910: Open-Label, Phase-2 Clinical Trial of Chlorambucil and Toceranib for Canine Mast Cell Tumors | Colorado State University | Kristen Weishaar, DVM, MS | Open | Oncology |
| 02858-A: Investigation of Mechanisms of Resistance to Immunotherapy in Dogs with Spontaneous High-grade Glioma | University of Minnesota | Susan Arnold, DVM | Open | Oncology |
| 02759: Reprogramming the Tumor Immune Niche in Canine Hemangiosarcoma | University of Minnesota | Jong Hyuk Kim, DVM, PhD | Open | Oncology - Hemangiosarcoma |
| 02783: Transcriptional Profiling of Canine Soft Tissue Sarcoma | Cornell University | Andrew D. Miller, DVM | Open | Oncology |
| 02780: Bladder Carcinogen Exposures in Pet Dogs | University of Wisconsin, Madison | Lauren Trepanier, DVM, PhD | Open | Oncology |
| 02758: Optical Coherence Tomography for Margin Evaluation of Canine Skin and Subcutaneous Neoplasms | The Ohio State University | Laura Selmic, BVetMed, MPH | Open | Oncology |
| 02773: Histotripsy for Treatment of Canine Appendicular Osteosarcoma | Virginia-Maryland Regional College of Veterinary Medicine | Joanne Tuohy, DVM, PhD | Open | Oncology - Osteosarcoma |
| 02746-A: Evaluation of Serum miRNA as a Diagnostic Tool for Canine Splenic Hemangiosarcoma | University of Georgia | Janet Grimes, DVM, MS | Open | Oncology - Hemangiosarcoma |
| 02782: Genetic Contribution to Early-onset Osteosarcoma | University of Wisconsin, Madison | Susannah Sample, DVM, MS, PhD | Open | Oncology - Osteosarcoma |
| 02772: Identifying Early Stage Ultra-rare Mutations as Predictive Biomarkers of Lymphoma in High-risk versus Low-risk Breeds Within the Dog Aging Project | University of Washington | Daniel Promislow, PhD | Open | Oncology - Lymphoma |
| 02739-A: The Role of the Putative Tumor Suppressor Gene SETD2 in Canine Diffuse Large B-cell Lymphoma | Michigan State University | Bonnie Harrington, DVM, PhD | Open | Oncology - Lymphoma |
| 02732-A: Tumor-educated Platelets: A Novel Minimally Invasive Liquid Biopsy for Early Cancer Diagnosis | Texas A&M AgriLife Research | Unity Jeffery, VetMB, PhD | Open | Oncology |
| 02534: Clinical Trial for Evaluation of Propranolol and Doxorubicin in the Treatment of Canine Hemangiosarcoma | University of Minnesota | Erin B. Dickerson, PhD and Antonella Borgatti, DVM, MS | Open | Oncology - Hemangiosarcoma |
| 02595-A: Defining the Flow Cytometric Characteristics of Normal and Diseased Canine Spleen and Visceral Lymph Nodes | University of Minnesota | Courtney E. Johnson, DVM | Open | Oncology |
| 02663: Comparative Brain Tumor Consortium (CBTC) Meningioma Pathology Board | National Institutes of Health/National Cancer Institute/Center for Cancer Research/Comparative Oncology Program, Cornell University, and University of Pennsylvania | Amy LeBlanc, DVM, Andrew Miller, DVM and Molly Church, MS, VMD, PhD | Open | Oncology |
| 02510-T: Identification of Novel Synthetic Lethal Partners to Optimize PI3K Targeted Therapies in Canine Hemangiosarcoma | Tufts University School of Medicine | Cheryl A. London, DVM, PhD | Open | Oncology - Hemangiosarcoma |
| 02487: OX40 Checkpoint Molecule Targeted Antibodies for Cancer Immunotherapy in Dogs | Colorado State University | Steven W. Dow, DVM, PhD | Open | Oncology |
| 02502: Precision Medicine for Canine Lymphoma | Trustees of the University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Open | Oncology - Lymphoma |
| 02519: Prevalence of Bartonella spp. Infection in Dogs with Cardiac and Splenic Hemangiosarcomas within and between Geographic Locations | North Carolina State University | Edward B Breitschwerdt, DVM; Matthew Breen, PhD | Open | Tick-Borne Disease Initiative , Oncology - Hemangiosarcoma |
| 02500: Immune Targeting of the V600E B-Raf Neoantigen in Canine Urothelial Carcinoma | University of Pennsylvania | Nicola J Mason, BVetMed, PhD | Open | Oncology |
| 02309-T: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma | University of Missouri | Angela McCleary-Wheeler, DVM, PhD | Open | Oncology - Lymphoma |
| 01660: Identifying the Genes That Confer Risk for Osteosarcoma | The Research Institute at Nationwide Children's Hospital | Carlos E. Alvarez, PhD | Open | Oncology - Osteosarcoma |
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.
